Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

Clinical Validation of BBCT-hip

Clinical Validation of BBCT-hip Methodology for Femur Fracture Risk Prediction

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The clinical study is aimed at assessing the accuracy of the in silico methodology BBCT-hip. BBCT-hip takes as inputs the subject-specific height and weight, and the CT scan of his femur to predict the risk of fracture for the femur upon falling. In the study, 150 subjects who suffered from a fracture will be enrolled, in addition to 150 control subjects. CT scans will be carried out for both groups (no later than 3 months for the fracture group) and BBCT-hip run,in order that the risk of fracture will be obtained. First, a transversal study will be performed, where the stratification accuracy of BBCT-hip will be assessed in terms of the ability of the predicted risk of fracture to separate fracture and control subjects. Furthermore, the control subjets will be followed up to assess BBCT-hip predictive accuracy through a longitudinal study.

Who May Be Eligible (Plain English)

Who May Qualify: - caucasic post-menopausal women resident in Emilia-Romagna - menopause (\>= 45 years) Who Should NOT Join This Trial: - tumours - not free living - Chronic diseases with severe organ failure / endocrine diseases of parathyroid, thyroid, adrenal gland / intestinal malabsorption, osteomalacia / Paget bone / rheumatoid arthritis. Neurodegenerative diseases - Long-term continuous therapy (\>3 months) with corticosteroids and proton pump inhibitors or aromatase inhibitors - Previous femur fractures - Presence of hip/knee prosthesis only for the fracturegroup: - presence of fixation devices after the fracture - femur fracture due to high energy trauma Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * caucasic post-menopausal women resident in Emilia-Romagna * menopause (\>= 45 years) Exclusion Criteria: * tumours * not free living * Chronic diseases with severe organ failure / endocrine diseases of parathyroid, thyroid, adrenal gland / intestinal malabsorption, osteomalacia / Paget bone / rheumatoid arthritis. Neurodegenerative diseases * Long-term continuous therapy (\>3 months) with corticosteroids and proton pump inhibitors or aromatase inhibitors * Previous femur fractures * Presence of hip/knee prosthesis only for the fracturegroup: * presence of fixation devices after the fracture * femur fracture due to high energy trauma

Treatments Being Tested

DIAGNOSTIC_TEST

CT scan at the femur

Additional CT scan which is not part of the standard clinical path

Locations (2)

Rizzoli Orthopaedic Institute
Bologna, Italy
Rizzoli Orthopaedic Institute
Bologna, Italy